Latest Breaking News On - Prnewswire fusion pharmaceuticals inc - Page 18 : comparemela.com
Fusion Pharmaceuticals and TRIUMF Announce Expanded R&D Collaboration for Actinium Supply Production
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals to Participate in the 2021 Wedbush PacGrow Healthcare Virtual Conference
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals enters into agreement to build radiopharmaceutical manufacturing facility
dotmed.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dotmed.com Daily Mail and Mail on Sunday newspapers.
Fusion Pharmaceuticals Announces First Quarter 2021 Financial Results and Business Update
News provided by
Share this article
Continuing expansion of pipeline of targeted alpha therapies through recently completed transactions
HAMILTON, ON and BOSTON, May 11, 2021 /PRNewswire/ Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced financial results for the first quarter ended March 31, 2021 and provided an update on clinical and corporate developments. We continue to advance our Phase 1 study of FPI-1434, said Chief Executive Officer John Valliant, Ph.D. In anticipation of data and determination of a recommended Phase 2 dose in the first half of 2022, we are amending the study protocol to define tumor-specific cohorts based upon IGF-1R expression and tumor uptake as seen to date in the Phase 1 study.